Reference number : 236-2015-2016-Q2-00051, amendment number : , agreement type : G, recipient legal name : Keillor, Jeffrey W, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1N 6N5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 100000.0, agreement start date : 2015-07-01, agreement end date : 2016-06-30, description english : Design, Synthesis and Evaluation of Transglutaminase Inhibitors as Potential Cancer Therapeutics, description french : Design, Synthesis and Evaluation of Transglutaminase Inhibitors as Potential Cancer Therapeutics, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2016-17), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2016-17), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada